Curant Health launched The Butterfly Collaboration in 2022, in partnership with Rare Advocacy Movement. The Butterfly Collaboration is a rare disease-focused campaign identifying life threatening issues rare disease patients experience, especially when transitioning from pediatric care to adult care. READ MORE
Limited/Exclusive Distribution
Detailed insights and customized reporting on product suitability, adverse events, side effects, drug interactions, and unmet patient needs.
High Touch Patient Support
Personalized and wholistic approach to patient care that focuses on the unique needs and challenges of rare disease patients.
Rare Disease Transitionary Experts
By tying into community, standardizing protocols, and helping rare disease patients with patient support, Curant Health has become a leader in helping all key stakeholders navigate the numerous transitions that a Rare Disease patient faces.
Cell & Gene Therapy Expertise
Supply chain services, product access management, high-touch patient support, and outcomes reporting to help Biopharma companies excel in their Cell & Gene Therapy efforts.
We are committed to excellence in the patients, partners, and communites we serve and uplift.
Our growing list of recognitions and accreditations highlight our ability to deliver sustained medication adherence and improved health outcomes while validating our mission to improve lives.
